Condition
Hemoadsorption
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting3
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07715110Not ApplicableNot Yet Recruiting
Biological Effects of Hemoadsorption in Septic Shock
NCT07679555RecruitingPrimary
Hemodynamic, Laboratory, and Clinical Outcomes of Hemoadsorption Therapy
NCT07127484Not ApplicableRecruiting
Hemoadsorption for Severe Ischemic Stroke
NCT07419802Recruiting
OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study
NCT06710834Not ApplicableCompleted
Comparing Hemodiafiltration with and Without Hemoadsorption
Showing all 5 trials